NewEdge Advisors’s Viemed Healthcare VMD Stock Holding History

NewEdge Advisors’s Portfolio VMD Stock Details VMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,459	Closed	-$174K	–	4413
2025 Q4	$174K	Buy	+23,459	New	+$161K	﹤0.01%	2621
2023 Q3	–	Sell	-200	Closed	-$1.96K	–	3668
2023 Q2	$1.96K	Hold	200	–	–	﹤0.01%	3101
2023 Q1	$1.93K	Buy	+200	New	+$1.74K	﹤0.01%	3038

Other funds holding VMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Forager Capital Management Birmingham, Alabama $201M AUM 9.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

NewEdge Advisors's VMD Position: Q1 2026 in Review

NewEdge Advisors sold out of Viemed Healthcare (VMD) in Q1 2026, closing a stake of 23,459 shares — an estimated $174K sold.

NewEdge Advisors first reported a position in VMD in Q1 2023 and held it in 3 quarters. The position peaked at $174K in Q4 2025. 149 funds tracked by Wall St. Rank hold VMD as of Q1 2026.

NewEdge Advisors reported no remaining Viemed Healthcare position as of Q1 2026 after selling out during the quarter.
NewEdge Advisors sold 23,459 Viemed Healthcare shares in Q1 2026, an estimated $174K.
NewEdge Advisors first reported a position in Viemed Healthcare in Q1 2023 and held it in 3 quarters.
NewEdge Advisors's Viemed Healthcare position peaked at $174K in Q4 2025.
149 funds tracked by Wall St. Rank held Viemed Healthcare as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.